These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6342656)

  • 21. A randomized trial comparing use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematological malignancies.
    Ringdén O; Bäckman L; Lönnqvist B; Heimdahl A; Lindholm A; Bolme P; Gahrton G
    Bone Marrow Transplant; 1986 May; 1(1):41-51. PubMed ID: 3332119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppression by Cyclosporin A in human renal transplant recipients.
    Ringdén O; Bergstrand A; Collste H; Grimfors G; Lundgren G; Groth CG
    Scand J Urol Nephrol Suppl; 1981; 64():220-9. PubMed ID: 6755683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephrotoxicity of cyclosporin A in humans: effects on glomerular filtration and tubular reabsorption rates.
    Dieperink H; Leyssac PP; Kemp E; Starklint H; Frandsen NE; Tvede N; Møller J; Buchler Frederiksen P; Rossing N
    Eur J Clin Invest; 1987 Dec; 17(6):493-6. PubMed ID: 3123248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential diagnosis of Cyclosporin A nephrotoxicity versus rejection by fine needle aspiration biopsy.
    Häyry P; von Willebrand E; Ahonen J
    Proc Eur Dial Transplant Assoc; 1983; 20():356-61. PubMed ID: 6361749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporin-associated nephropathy in patients with autoimmune diseases.
    Mihatsch MJ; Bach JF; Coovadia HM; Førre O; Moutsopoulos HM; Drosos AA; Siamopoulos KC; Noël LH; Ramsaroop R; Hällgren R
    Klin Wochenschr; 1988 Jan; 66(2):43-7. PubMed ID: 3347004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The determination of metabolite M17 and its meaning for immunosuppressive cyclosporin therapy.
    Khoschsorur G; Auer T; Lanzer G; Petritsch P; Holzer H; Tscheliessnigg KH
    Angiology; 1998 Apr; 49(4):307-14. PubMed ID: 9555934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of serum cyclosporine concentration with renal dysfunction in marrow transplant recipients.
    Kennedy MS; Yee GC; Mcguire TR; Leonard TM; Crowley JJ; Deeg HJ
    Transplantation; 1985 Sep; 40(3):249-53. PubMed ID: 3898489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertension in bone marrow transplanted patients.
    De Plaen JF; Ferrant A; Michaux JL; van Ypersele de Strihou C
    Acta Clin Belg; 1989; 44(5):295-302. PubMed ID: 2692366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted blood levels of cyclosporin for cardiac transplantation.
    Griffith BP; Hardesty RL; Trento A; Lee A; Bahnson HT
    J Thorac Cardiovasc Surg; 1984 Dec; 88(6):952-7. PubMed ID: 6389991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regeneration of peripheral blood cells following allogeneic bone marrow transplantation for severe aplastic anaemia.
    Hows JM; Kaffaf S; Palmer S; Harris R; Fairhead S; Gordon-Smith EC
    Br J Haematol; 1982 Dec; 52(4):551-8. PubMed ID: 6753913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer cell activity against a thymoma cell line Thy 121 in bone marrow transplant recipients.
    Heidemann E; Schmidt H; Schüch K; Ostendorf P; Waller HD
    Klin Wochenschr; 1986 Feb; 64(3):125-30. PubMed ID: 3512902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indirect assessment of renal dysfunction in patients taking cyclosporin A for autoimmune diseases.
    Mason J; Moore LC
    Br J Dermatol; 1990 Jun; 122 Suppl 36():79-84. PubMed ID: 2369571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation between allograft rejection and cyclosporin nephrotoxicity in renal-transplant recipients.
    Taube DH; Neild GH; Williams DG; Cameron JS; Hartley B; Ogg CS; Rudge CJ; Welsh KI
    Lancet; 1985 Jul; 2(8448):171-4. PubMed ID: 2862369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal function after 10 years' treatment with cyclosporin for psoriasis.
    Powles AV; Hardman CM; Porter WM; Cook T; Hulme B; Fry L
    Br J Dermatol; 1998 Mar; 138(3):443-9. PubMed ID: 9580797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between cyclosporin neurotoxicity and hypomagnesaemia.
    Thompson CB; June CH; Sullivan KM; Thomas ED
    Lancet; 1984 Nov; 2(8412):1116-20. PubMed ID: 6150182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporin A as prophylaxis against graft-versus-host disease in 36 patients.
    Barrett AJ; Kendra JR; Lucas CF; Joss DV; Joshi R; Pendharkar P; Hugh-Jones K
    Br Med J (Clin Res Ed); 1982 Jul; 285(6336):162-6. PubMed ID: 6807391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial.
    Storb R; Deeg HJ; Pepe M; Doney K; Appelbaum F; Beatty P; Bensinger W; Buckner CD; Clift R; Hansen J
    Br J Haematol; 1989 Aug; 72(4):567-72. PubMed ID: 2673331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphological differentiation between rejection and cyclosporin nephrotoxicity in renal allografts.
    Neild GH; Taube DH; Hartley RB; Bignardi L; Cameron JS; Williams DG; Ogg CS; Rudge CJ
    J Clin Pathol; 1986 Feb; 39(2):152-9. PubMed ID: 3512613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nephrotoxicity of cyclosporin A in liver and kidney transplant patients.
    Klintmalm GB; Iwatsuki S; Starzl TE
    Lancet; 1981 Feb; 1(8218):470-1. PubMed ID: 6110092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood cyclosporin concentrations and renal allograft dysfunction.
    Holt DW; Marsden JT; Johnston A; Bewick M; Taube DH
    Br Med J (Clin Res Ed); 1986 Oct; 293(6554):1057-9. PubMed ID: 3094774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.